Moderna’s oncology pipeline also includes a Merck-partnered personalized cancer vaccine called intismeran autogene or ...

A study has found that COVID-19 mRNA vaccines unexpectedly enhance the effectiveness of immunotherapy for lung and skin ...

New research suggests Covid-19 mRNA vaccines offer benefits beyond viral protection. These vaccines may boost the immune ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

Groundbreaking research reveals mRNA COVID-19 vaccines may significantly boost cancer immunotherapy success. Patients ...

A vaccine originally designed to protect against Covid-19 has shown unexpected promise in helping the immune system fight ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

To further back their findings, University of Florida researchers replicated the effect in mice. They paired immunotherapy ...

A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Tsinghua ...

The Department of Health and Human Services recently cut $500 million in mRNA research funding. “mRNA technology poses more ...

Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...